Oxford VR secures €11.9 million to expand its virtual reality therapy across the US

Oxford VR Closes £10m Series A Funding

Oxford VR, a UK-based startup developing virtual reality therapy solutions, has secured €11.9 million in Series A funding led by Optum Ventures and Luminous Ventures. The funding will be used to expand the company's US operations and its treatment pipeline. Oxford VR, a spinout from Oxford University's Department of Psychiatry, has a strong foundation in evidence-based research and aims to revolutionize mental health therapy through immersive technology. The company has established partnerships with the National Mental Health Innovation Centre (NMHIC) in the US and AXA Hong Kong and The Chinese University of Hong Kong (CUHK) in Asia to expand its reach and impact.

Oxford VR Raises €11.9 Million to Expand Virtual Reality Therapy in the US

Oxford VR is a UK-based startup that develops virtual reality therapy solutions for mental health conditions. Founded as a spinout from Oxford University's Department of Psychiatry, the company leverages two decades of research by Professor Daniel Freeman to create evidence-based, automated virtual reality treatments. Their first clinical trial, published in The Lancet Psychiatry, focused on fear of heights and demonstrated the effectiveness of automated VR therapy in improving patient outcomes and expanding treatment reach.

Oxford VR develops virtual reality therapy solutions for mental health conditions.

5 years ago

Oxford VR Raises €11.9 Million to Expand Virtual Reality Therapy in the US

ProblemHealthcare

Solution

Covered on